bims-pideca Biomed News
on Class IA PI3K signalling in development and cancer
Issue of 2026–11–01
twenty papers selected by
Ralitsa Radostinova Madsen, MRC-PPU



  1. Cell Rep. 2026 Oct 26. pii: S2211-1247(26)01293-3. [Epub ahead of print]45(11): 118214
      AKT hyperactivation is a hallmark of many human cancers and contributes to poor clinical outcomes, yet the underlying mechanisms remain incompletely understood. Here, we show that AKT undergoes UFMylation, and loss of AKT UFMylation promotes colorectal tumor development and confers resistance to the AKT inhibitor AZD5363 (capivasertib). Furthermore, p53 activates ubiquitin-fold modifier 1 (UFM1) during the cell cycle to inhibit AKT activity. Conversely, AKT phosphorylates UFM1 to reduce its own UFMylation, establishing a feedback loop that sustains AKT activity. Moreover, we provide evidence that UFSP2 functions as a major cellular deUFMylase for AKT, and genetic ablation or inhibition of UFSP2 suppresses AKT activity to retard tumorigenesis in vivo. Together, these findings provide a mechanistic framework for UFMylation-dependent AKT regulation and support further investigation of UFSP2 inhibition as a potential strategy to modulate AKT signaling in colorectal cancer.
    Keywords:  14-3-3; AKT; AKT inhibitor; CP: cancer research topic 2:; CP: molecular biology; UFL1; UFMylation; UFSP2; capivasertib; phosphorylation; tumorigenesis
    DOI:  https://doi.org/10.1016/j.celrep.2026.118214
  2. Elife. 2026 Oct 30. pii: RP106338. [Epub ahead of print]14
      The molecular mechanisms that drive (lymph-)angiogenesis are crucial to understanding diseases, such as lymphedema, that are caused due to malformations of the lymphatic vasculature. Recently, an interaction between the secreted protein Svep1, a key regulator in lymphangiogenesis, and the transmembrane receptor Tie1 was shown in zebrafish, humans, and mice. Here, guided by in silico AlphaFold-multimer structure predictions of SVEP1 complexes, we assert with protein binding studies that the human CCP20 domain is the primary binding site for TIE1. We further demonstrate that SVEP1 mediates strong binding of ANG2 and TIE1, and that combined stimulation of hdLECs with SVEP1 and ANG2 leads to phosphorylation of TIE1. TIE1 activation by SVEP1 and ANG2 enables downstream signaling and, in turn, potentiates nuclear exclusion of FOXO1 and phosphorylation of AKT compared to SVEP1 or ANG2 alone. We present a model in which ANG1/2 dimers bind to both SVEP1 and TIE1, resulting in the recruitment of multiple TIE1 receptor molecules to a multimeric complex at the cell membrane, potentially amplifying its signaling capacity.
    Keywords:  cell biology; growth factors; human; lymphangiogenesis; receptors; signaling; vascular biology
    DOI:  https://doi.org/10.7554/eLife.106338
  3. Autophagy. 2026 Oct 26. 1-28
      The retinal pigment epithelium (RPE) sustains lifelong proteostasis under chronic stress, yet how post-mitotic cells activate macroautophagy/autophagy when canonical kinase pathways suppress it remains unresolved. Here we demonstrate that AKT1 (protein kinase B alpha), drives autophagy through a non-canonical transcriptional mechanism triggered by isoform imbalance. In RPE and age-related macular degeneration (AMD) models, AKT2 (protein kinase B beta) hyperactivation destabilizes MTORC2 (mechanistic target of rapamycin complex 2) and engages RPS6KB/S6K (ribosomal protein S6 kinase beta) -mediated IRS-1 (insulin Receptor Substrate 1) inhibition, creating a feedforward autophagic arrest. Compensatory AKT1 activation via MTORC2 phosphorylates TERT (telomerase reverse transcriptase) at serine 824, driving nuclear translocation that is independent of telomere maintenance. In the nucleus, TERT assembles with FOXO3 (forkhead Box O3) and MYC (MYC proto-oncogene, bHLH transcription factor) into a tripartite transcriptional complex that occupies the EIF2AK3/PERK promoter (eukaryotic translation initiation factor 2-alpha kinase 3/ protein kinase R-like endoplasmic reticulum kinase), enabling EIF2AK3 transcriptional activation. This activity converts the unfolded protein response from pro-apoptotic to cytoprotective: EIF2AK3-ATF4 (activating transcription factor 4) signaling promotes core autophagy machinery biogenesis and selective ERphagy through the receptors TEX264 (testis expressed 264) and CCPG1(cell cycle progression 1), which prevents pathological EIF2AK3 clustering and preserves tubular ER architecture in diseased RPE. Using C. elegans phosphorylation-deficient mutants, mouse models and AMD patient iPSC-RPE, we establish that AKT1-mediated TERT phosphorylation is an evolutionarily conserved prerequisite for FOXO/DAF-16 nuclear function and lysosomal homeostasis in post-mitotic cells, offering therapeutic potential through targeted pharmacologic inhibition of AKT2.Abbreviations: ACTB: actin, beta; AKT1: AKT serine/threonine kinase 1; AKT2: AKT serine/threonine kinase 2; ALP: autophagy-lysosomal pathway; AMD: age-related macular degeneration, ATF4: activating transcription factor 4; ATG3: autophagy related 3; ATG4B: autophagy related 4B cysteine peptidase; ATG7: autophagy related 7; CCPG1: cell cycle progression 1; CFH: complement factor H; C57BL/6J: C57 black 6J; DMSO: dimethyl sulfoxide; MYC: MYC proto-oncogene, bHLH transcription factor; EIF2A/eIF2α: eukaryotic translation initiation factor 2A; EIF2AK3/PERK: eukaryotic translation initiation factor 2 alpha kinase 3; ER: endoplasmic reticulum; ERN1/IRE-1α: endoplasmic reticulum to nucleus signaling 1; ERphagy: endoplasmic reticulum-selective autophagy; FOXO1: forkhead box O1; FOXO3: forkhead box O3; iPSC-RPE: induced pluripotent stem cell-derived retinal pigment epithelium; ITGB1/integrin β1: integrin subunit beta 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPKAP1/SIN1: MAPK associated protein 1; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; MTORC2: MTOR complex 2; PBS: phosphate-buffered saline; PI3K: phosphoinositide 3-kinase; RICTOR: RPTOR independent companion of MTOR complex 2; RPE: retinal pigment epithelium; RPTOR: regulatory associated protein of MTOR complex 1; SQSTM1/p62: sequestosome 1; TERT: telomerase reverse transcriptase; TEX264: testis expressed 264, ER-phagy receptor; UPR: unfolded protein response; VCL: vinculin; WT: wild type.
    Keywords:  AKT1; Age-Related Macular Degeneration (AMD); EIF2AK3/PERK-ATF4 signaling; Telomerase Reverse Transcriptase (TERT); autophagy/Erphagy; proteostasis
    DOI:  https://doi.org/10.1080/15548627.2026.2750048
  4. bioRxiv. 2026 Sep 03. pii: 2026.09.01.748636. [Epub ahead of print]
    Somatic Mosaicism across Human Tissues Network
      Although all cells in the body descend from one genome, they accumulate distinct genetic and epigenetic changes over a lifetime, producing a mosaic of somatic variation that can shape development, aging, and disease. This mosaicism is often studied in isolation, leaving unclear how these forms relate within and between individuals. Here, we present the first integrated analysis of the Somatic Mosaicism across Human Tissues (SMaHT) Network's production resource, profiling up to 20 tissues from 25 donors using short- and long-read, duplex, single-cell, transcriptomic, and epigenomic sequencing, alongside donor-specific near-telomere-to-telomere assemblies. Somatic mutation burden cannot be captured by a single data type or metric, as tissues accumulate distinct variant classes largely independently of one another. Long-read and single-cell data resolved cell-type-specific mutational processes, traced mobile element insertions to source loci, and revealed the developmental timing and functional consequences of individual mutations. Donor-specific assemblies uncovered elevated mutation rates within centromeres and segmental duplications inaccessible to standard reference genomes, while haplotype-resolved chromatin and methylation data showed that nongenetically-deterministic epigenetic states are pervasive across tissues. Together, these findings provide an integrated, multi-scale portrait of somatic mosaicism across the human body, establishing a baseline against which its contributions to aging and disease can be measured.
    DOI:  https://doi.org/10.64898/2026.09.01.748636
  5. Mol Cells. 2026 Oct 27. pii: S1016-8478(26)00099-3. [Epub ahead of print] 100408
      Cellular senescence is a stable cell cycle arrest, which has a crucial role in organismal aging and many chronic diseases. Here, we present an updated MiniResource that extends the methods for mammalian senescence assays, including analyses of cell cycle arrest and cellular morphology, changes in transcriptomic signatures, and fluorescence-based tools. This work will provide practical guidance to help researchers design appropriate experiments for assessing cellular senescence.
    Keywords:  Aging; Cell cycle arrest; Senescence; Senescence-associated secretory phenotype; Senescence-associated transcriptional profiles; Senescent hypertrophy
    DOI:  https://doi.org/10.1016/j.mocell.2026.100408
  6. bioRxiv. 2026 Oct 09. pii: 2026.10.06.757133. [Epub ahead of print]
      Extracellular matrix (ECM)-mediated cell adhesion and tension regulate development and disease through crosstalk with Receptor Tyrosine Kinases (RTKs). RTKs stimulate proliferation, survival, and metabolic reprogramming via Ras/ERK and PI3K/Akt signaling. Emerging evidence identify the biophysical and biochemical integration of integrin-mediated adhesions with RTK signaling, however, the molecular mechanisms regulating this phenotype remain poorly understood. Here, we demonstrate that ECM stiffness potentiates ligand-mediated epidermal growth factor receptor (EGFR) signaling at scales ranging from the single adaptor protein, Grb2 upward to multicellular spheroids and tissues. We show that ECM stiffness-driven RTK signaling is mediated by integrin adhesions that reshape the membrane to induce the formation of RTK signaling hotspots distributed globally across the cell membrane. A parsimonious computational model and biochemical membrane perturbations causally implicate membrane curvature and topography in tension-dependent integrin-EGFR crosstalk. The results demonstrate how the mechanical properties of the ECM direct molecular recruitment and confinement of signaling molecules to regulate growth factor-dependent RTK signaling. Given that many RTK-driven solid tumors develop a stiff stroma, the findings could explain why many therapeutic tyrosine kinase inhibitors develop clinical resistance. The findings suggest clarifying how tension regulates transmembrane receptor signaling could identify unique force-dependent molecular regulators towards which new antitumor therapies could be applied.
    DOI:  https://doi.org/10.64898/2026.10.06.757133
  7. bioRxiv. 2026 Oct 06. pii: 2026.10.05.756815. [Epub ahead of print]
      Lymphatic endothelial cell (LEC) function is strongly tied to transitions between button- and zipper-like junctions that control fluid flow into vessels. Published methods quantifying junction morphology are limited to single cell analysis or use few quantitative metrics to describe junctions across LEC monolayers. Therefore, a novel 3-step image analysis pipeline was developed to identify new metrics that quantify differences in button- and zipper-like junctions in LECs. The pipeline used Cellpose, CellProfiler, and Fiji to analyze VE-cadherin expression across lymphatic vessels within a 3D microfluidic chip and quantify VE-cadherin radial intensity, number of objects, object size, branchpoints, endpoints, and junction thickness. Tumor necrosis factor (TNF)-α exposure produced button-like junctions, and unexposed cells were zippered. Radial intensity was heightened at the cell membrane in zipper-like junctions while perinuclear intensity increased for button-like junctions. Increased branchpoints, endpoints, objects per cell, and junction thickness were associated with junction buttoning, while increased object size was associated with junction zippering. Principle component analysis results reinforced these trends and identified metric combinations that represented each junctional state. Overall, this semi-automated pipeline quantified differences in VE-cadherin junction morphology across LEC monolayers and generated new quantitative metrics to expand the tools available for studying junction morphology in lymphatic vasculature.
    DOI:  https://doi.org/10.64898/2026.10.05.756815
  8. Cell Rep. 2026 Oct 26. pii: S2211-1247(26)01280-5. [Epub ahead of print]45(11): 118201
      The RAS/RAF/MEK/ERK pathway has been extensively studied for its roles in physiology and disease, yet a systems-level view of its interplay with the broader cellular context is lacking, limiting insight into paralog-specific roles, mutation-driven rewiring, and cross-pathway integration. To address this, we simultaneously mapped the interactomes of all pathway components and their activating and inactivating mutations, identifying 2,500 high-confidence interactors, 88% of which previously unreported, and generating a high-confidence, comprehensive reference map of the pathway in resting and activated states. The pathway behaves like a "molecular organism" that connects to other signaling complexes, operates from distinct subcellular sites, and integrates into networks relevant to physiology and disease. Dataset exploration uncovers paralog- and mutation-specific interaction signatures and pathway-level crosstalk, including previously unknown connections to mRNA metabolism and WNT signaling. The interactomes available at RAStoERK.univie.ac.at provide a foundational community resource for unbiased discovery, targeted mechanistic studies, and potential therapeutic exploration.
    Keywords:  AP-MS; CP: molecular biology; RAS-RAF-MEK-ERK pathway; cancer signaling; interactome; network biology; oncogenic mutations; pathway crosstalk; protein-protein interactions; proteomics; proximity labeling
    DOI:  https://doi.org/10.1016/j.celrep.2026.118201
  9. bioRxiv. 2026 Oct 09. pii: 2026.10.07.757149. [Epub ahead of print]
      MYC amplification is the most common genetic alteration in radiation-associated angiosarcoma and is also present in a subset of de novo primary angiosarcoma, yet its oncogenic role in this vascular malignancy remains unclear. Here, we report that inducible, endothelial-specific MYC overexpression alone was sufficient to drive angiosarcomagenesis in mice. The resulting pulmonary angiosarcoma tumors exhibited impaired endothelial differentiation, indicative of MYC-driven lineage plasticity. Notably, MYC inactivation in dedifferentiated allografts induced growth arrest and restored endothelial gene expression, demonstrating MYC-dependent reversible cellular plasticity. Integrative analyses of MYC ChIP-seq, ATAC-seq, and RNA-seq revealed that overexpressed MYC preferentially occupied highly accessible promoters and activated genes involved in cell growth. Consistent with the murine findings, MYC -amplified human angiosarcomas were enriched for MYC target and cell-cycle programs and depleted of endothelial lineage signatures. MYC overexpression in human endothelial and angiosarcoma cells recapitulated these transcriptional changes, enhanced proliferation, and impaired endothelial tube formation. Together, our results establish MYC as an oncoprotein that promotes endothelial lineage plasticity to drive angiosarcoma initiation and progression.
    DOI:  https://doi.org/10.64898/2026.10.07.757149
  10. PLoS One. 2026 ;21(10): e0361303
      Upon ligand binding, the kinase domain of EGFR phosphorylates multiple tyrosine residues on the receptor cytoplasmic tail through a trans-autophosphorylation process. Phosphotyrosine sites on activated receptors recruit Grb2, which further recruits SOS to initiate downstream signaling by activating Ras. Multivalent binding between SOS and Grb2, as well as direct Grb2:Grb2 interactions, contribute to formation of a protein condensate of activated EGFR. The condensed state of EGFR facilitates autoinhibition release in SOS and exerts regulatory control over signal propagation from activated EGFR to Ras. While kinase activity of EGFR is an essential driver of this signaling process, phosphorylation at residue Y160 on Grb2 blocks Grb2:Grb2 binding and can interfere with EGFR condensation. Here, using a reconstituted system, we examine how titrating kinase activity in the EGFR system can both promote and inhibit signal output to Ras. The results reveal how effects of tyrosine kinase inhibition can, under some circumstances, promote Ras activation by inhibiting negative feedback through Grb2 phosphorylation and disruption of a Grb2 SH2/SH3 dimer interface.
    DOI:  https://doi.org/10.1371/journal.pone.0361303
  11. bioRxiv. 2026 Sep 03. pii: 2026.03.09.710634. [Epub ahead of print]
      Quantitative fluorescence microscopy is central to modern cell biology, yet experimentalists lacking computational expertise have limited ability to extract reproducible measurements from the images they collect. Here we present cellquant , a pipeline to analyze multi-channel fluorescence images that performs cell segmentation, subcellular localization and colocalization analyses, morphometric quantification, and spatial proximity calculations in two or three dimensions. By replacing the requirement for computational expertise with iterative assistance from large language models (i.e., "vibecoding"), cellquant enables experimentalists with any level of coding experience to quantify imaging data. We validate cellquant on stress granule formation in human HCT116 cells and nucleolar reorganization across a temperature gradient in budding yeast. Dimensionality reduction of a 45-feature output from 8,309 yeast cells resolved cell state transitions and revealed subpopulations of non-responders. Because the cellquant interface is text based, the exact command used in any analysis can be recorded and re-executed, generating reproducible quantification with visual quality control and statistical rigor. Code, documentation, and datasets are freely available.
    DOI:  https://doi.org/10.64898/2026.03.09.710634
  12. J Cell Biol. 2026 Dec 07. pii: e202510232. [Epub ahead of print]225(12):
      Membrane trafficking is regulated by the spatiotemporal distribution of phosphoinositides. The endolysosomal pathway is controlled by PI3P, PI(4,5)P2 and PI(3,5)P2, whereas a role for PI(3,4,5)P3 is less clear. We report that Saccharomyces cerevisiae produces PI(3,4,5)P3 through Vps34 activity using PI(4,5)P2 as a substrate. In vitro assays showed that dioctanoyl (C8) PI(3,4,5)P3, the PI(3,4,5)P3-binding domain Grp1-PH, and the phosphatase PTEN blocked vacuole fusion. Fluorescence microscopy showed that PI(3,4,5)P3 was present on vacuoles and the plasma membrane and that its presence was eliminated by inhibiting Vps34. Importantly, PI(3,4,5)P3 was required for the enrichment of Ypt7 and the HOPS subunit Vps33 at vertex domains. Blocking PI(3,4,5)P3 also caused the release of the soluble SNARE Vam7, leading to inhibited trans-SNARE pairing. Finally, we show that PI(3,4,5)P3 is needed for vacuole acidification in vivo. These results demonstrate that PI(3,4,5)P3 affects multiple factors in vacuole function.
    DOI:  https://doi.org/10.1083/jcb.202510232
  13. bioRxiv. 2026 Oct 25. pii: 2026.10.04.756099. [Epub ahead of print]
      Variation alters inherent protein properties like thermodynamic stability and catalytic activity, and these intrinsic effects are shaped by the cellular environment. The RAS-MAPK signaling pathway typifies this interplay, with hundreds of proteins acting in concert through regulated states and interactions to transduce signals. To explore how cell context influences variant effects, we measured the abundance and pathway activity of 186,676 variants across 17 MAPK proteins in human cells under diverse conditions, for a total of 503,099 measurements. We discovered 14,412 dominant negative variants, nearly all previously unknown, that disrupt specific domains or interaction interfaces while preserving other functions. MAPK dominant negatives occur at conserved positions and are depleted from the human population relative to other activity-altering variants, representing a distinct constraint on the human genome. Modulating chaperone activity exposed previously hidden effects of genetic variation on protein abundance in human cells, revealing the HSP90 dependence of 67% of missense variants across the pathway. Combining hundreds of experimental and predicted protein interaction structures with variant effect data distinguished functional from non-functional interaction interfaces and revealed how their disruption affected function. We resolved the overlapping KRAS-LZTR1-SOS1 interface into partner-specific and shared binding determinants, identified allosteric networks supporting each interaction, and uncovered distinct mechanisms by which variants promote LZTR1-mediated degradation. Thus, we measure variant effects at pathway scale in human cells, illuminating fundamental MAPK pathway signaling mechanisms and demonstrating that cellular context profoundly shapes the effect of most variants.
    DOI:  https://doi.org/10.64898/2026.10.04.756099
  14. JHEP Rep. 2026 Oct 26. pii: S2589-5559(26)00354-X. [Epub ahead of print] 102083
       BACKGROUND AND AIMS: Patient-derived organoids (PDO) are three-dimensional cultures established from cancer tissues. While PDOs can replicate morphology and drug sensitivity of cancer from given patients, their clinical applicability is limited by their lack of integration in clinical trials. We aimed to define the establishment rate of PDOs from patients with cholangiocarcinoma (CCA) and establish a protocol for the generation of PDOs from cryopreserved tissue.
    METHODS: We established a biobank of PDOs from tumour tissues (N=26). A protocol for organoid establishment from cryopreserved tissue was optimised in mice, confirmed in human PDO, and validated across institutions.
    RESULTS: While we started from a wide enrolment of different subtypes, including Pancreatic cancer (N=7), CCA (N=11), duodenal (N=2) and Ampullary Cancer (N=6), we refined the protocol towards biliary phenotype, with reduced efficiency rate in intestinal phenotype cancers. In total, 15 PDOs were established (58%); in the CCA cohort the efficiency rate of 75% (8 out of 11). Confirmation of organoid tumour origin was achieved through pathology review within a clinically-relevant time frame [median: 1.6 months (0.43-4.83 months)]. There was no numerical enrichment of successful PDO establishment for CCAs with poor prognostic factors such as perineural invasion, vascular invasion, nodal status and resection margins (p>0.05). Data from drug screening was ready within an average of 3 months from tissue collection (range:1.4-3.4 months). PDO from cryopreserved tissue was successful in 67% of cases and maintained the morphology, secretory functions, kinetic and dynamic growth patterns, transcriptomics, and drug sensitivity compared to organoids established from fresh tissues.
    CONCLUSIONS: Cryopreserved tissue can facilitate the centralisation of PDO establishment and thus, the integration of biliary PDOs in multicentric trials.
    Keywords:  biliary tract; cholangiocarcinoma; cryopreserved; organoids
    DOI:  https://doi.org/10.1016/j.jhepr.2026.102083
  15. J Cell Sci. 2026 Nov 01. pii: jcs264943. [Epub ahead of print]139(21):
      Spatial chromatin organization dictates cellular function and resilience, yet scalable imaging methods to quantify chromatin states in situ across aging and interventions are lacking. Although ATAC-see can visualize accessible chromatin, its broader application is hindered by protocol variability, low throughput and incompatibility with complex tissues. Here, we systematically optimize the ATAC-see workflow for robust, high-throughput quantitative imaging in fixed, adherent mammalian cells and fresh frozen tissues. We validate the sensitivity of the platform to pharmacologic remodeling and apply it to replicative, chronological and pathological aging in primary human fibroblasts, revealing progressive age-associated chromatin opening and heterochromatin remodeling. Furthermore, we demonstrate that our optimized ATAC-see captures rapid, reversible chromatin reorganization during OSK(M)-driven partial reprogramming of aged fibroblasts. Finally, we extend a cost-effective and accessible protocol to murine tissue sections, quantifying in situ age-dependent remodeling. This standardized framework establishes chromatin accessibility as a highly scalable, sequencing-compatible imaging biomarker for evaluating aging and rejuvenation.
    Keywords:  ATAC; ATAC-see; Aging; Cellular reprogramming; Chromatin accessibility; Epigenetics
    DOI:  https://doi.org/10.1242/jcs.264943
  16. ACS Chem Biol. 2026 Oct 29.
      Mammalian cells control a wide range of essential processes via protein-protein interactions (PPIs), including signal transduction, gene expression, cell cycle regulation, and metabolism. Pathologic alterations in PPIs have been linked to many human diseases. Thus, the ability to rapidly and selectively induce PPIs in cultured cells is crucial for many fields of biological research. One proven approach is the use of synthetic bivalent chemical ligands to selectively recruit protein domains with engineered mutations (i.e., "bump-and-hole"). Developing new PPI chemical inducers with unique protein domains enables multiplexing and potentially expands the breadth of recruitable proteins. Herein, we describe the design and characterization of a BromoTag- and dTAG-based toolkit to induce protein homo- and heterodimerization. Using a NanoBiT split-luciferase assay, we characterized a library of BromoTag-based homo- (BromoTag/BromoTag) and heterobivalent (BromoTag/dTAG) compounds for their ability to induce neo-PPIs. Compounds were evaluated for activity across multiple cellular applications, including caspase-9 and c-Kit tyrosine kinase activation, with comparable activity to other dimerizer systems. This BromoTag-based protein dimerization toolkit provides a useful alternative to current controlled dimerization systems that will enable robust prototyping of chemically induced proximity.
    DOI:  https://doi.org/10.1021/acschembio.6c00616
  17. bioRxiv. 2026 Oct 06. pii: 2026.10.05.756772. [Epub ahead of print]
      Endothelial cells integrate biomechanical and biochemical cues to regulate vascular function, which can be modeled using cell signaling networks. Yet, the extent to which their signaling behavior is determined by network topology versus reaction-specific parameterization remains unclear. We developed a continuous logic-based ordinary differential equation model of vascular endothelial signaling containing 70 species and 123 regulatory reactions assembled from the literature. Model predictions were evaluated against 78 literature-defined directional responses to increased wall stress, wall shear stress, hypoxia, and TNF α . We first tested whether a single global parameter triplet describing reaction weight ( w ), Hill coefficient ( n ), and half-maximal activation ( EC 50 ) could reproduce these observations. Investigator-selected global parameters reproduced 62 of 78 responses (79.49%). Monte Carlo sampling of 100,000 globally constant parameter sets improved agreement to 69 of 78 responses (88.46%), indicating that network topology alone captured most qualitative signaling behavior but remained sensitive to parameter choice. Allowing reaction-specific parameters increased the best agreement to 75 of 78 responses (96.15%). We then used a genetic algorithm to identify the smallest subset of reactions requiring reaction-specific specification while retaining a common constant-parameter spine for the remainder of the network. Complete agreement (100%) with all 78 literature-defined responses was achieved with reaction-specific parameterization of only 10 of 123 reactions. The optimized model was subsequently used to simulate continuous changes in wall shear stress, revealing pathway-dependent nonlinear responses, including monotonic increases in nitric oxide and pSmad1/5, nonmonotonic responses in endothelin-1 and NF-κB, and a biphasic pSmad2/3 response. These findings show that most observed endothelial signaling behavior can be reproduced by a fixed network topology with broadly shared reaction parameters with only a limited subset of interactions requiring quantitative specialization. This framework provides a compact endothelial signaling model for investigating mechanobiological regulation and for future integration with multiscale models of vascular adaptation and disease.
    DOI:  https://doi.org/10.64898/2026.10.05.756772
  18. STAR Protoc. 2026 Oct 29. pii: S2666-1667(26)00580-0. [Epub ahead of print]7(4): 104927
      Large genomic region modification, such as precise haplotype reconstitution, remains challenging due to the low efficiency of homology-directed repair (HDR) and difficulties in generating HDR templates. Here, we present a two-stage protocol for genome engineering in human induced pluripotent stem cells (hiPSCs) using CRISPR-Cas9 to generate homozygous, multi-kilobase isogenic haplotypes. We describe steps for in silico experimental design, large haplotype deletion and reconstruction, followed by edited cell line validation. This optimized protocol improves both editing efficiency and screening throughput while reducing turnaround time. For complete details on the use and execution of this protocol, please refer to Xue et al.1.
    Keywords:  CRISPR; Molecular Biology; Stem Cells
    DOI:  https://doi.org/10.1016/j.xpro.2026.104927
  19. bioRxiv. 2026 Oct 07. pii: 2026.10.06.757084. [Epub ahead of print]
      KRAS signaling is spatially organized within the dynamic proteolipid nanoclusters on the plasma membrane (PM) that selectively concentrate anionic phospholipids, yet the molecular determinants governing this lipid sorting remain incompletely defined. Here we identify phospholipid acyl chain composition as a critical regulator of KRAS spatial organization and signal output. Using genetic and pharmacological perturbation of lysophosphatidylcholine acyltransferase 3 (LPCAT3), a key enzyme that incorporates polyunsaturated fatty acids into phospholipids, we demonstrate that remodeling of membrane acyl chain unsaturation alters the phosphatidylserine (PS) lipidome without changing total PS abundance. Loss of LPCAT3 depletes polyunsaturated PS species, disrupts KRAS PM association and nanoclustering, and attenuates downstream MAPK signaling and oncogenic activity across multiple KRAS mutant contexts. Acute restoration of polyunsaturated, but not saturated, lipids rescue KRAS nanoclustering, establishing a direct requirement for lipid unsaturation in sustaining signaling-competent assemblies. Mechanistically, these findings define membrane acyl chain composition as a determinant of proteolipid organization that encodes KRAS signaling capacity. Consistent with this model, LPCAT3 inhibition selectively impairs KRAS-dependent proliferation and sensitizes tumor cells to direct KRAS inhibition. Together, this work uncovers lipid acyl chain remodeling as a fundamental regulator of membrane-associated signaling and identifies membrane composition as an exploitable vulnerability in oncogenic KRAS systems.
    DOI:  https://doi.org/10.64898/2026.10.06.757084
  20. Cardiovasc Res. 2026 Oct 26. pii: cvag242. [Epub ahead of print]
       AIMS: Mature, contractile vascular smooth muscle cells (vSMC) in muscular blood vessels can de-differentiate into synthetic vSMC, while human pluripotent stem cells (hPSC) differentiate into proliferating, fetal-like vSMC that can be induced to form contractile vSMC. Given the complicated embryonic origins and conflicting views on vSMC heterogeneity, our aim was to establish how closely hPSC-vSMC of a known germ layer lineage and defined phenotype are representative of vSMC obtained from aorta (AoSMC).
    METHODS AND RESULTS: We generated paraxial mesoderm (PM)-derived synthetic and contractile vSMC from hPSC lines and performed phenotypic and mechanical comparisons with AoSMC. Synthetic hPSC-vSMC and cultured AoSMC are proliferative, sensitive to contact inhibition and exhibit phenotype switching. Contractile hPSC-vSMC are non-proliferative, capable of phenotype switching and have elevated levels of contractile proteins (CNN1, TAGLN, ACTA2). These contractile proteins also displayed density-dependent, cell-to-cell heterogeneity in both AoSMC and hPSC-vSMC. Single-cell traction force measurements on micropost array detectors (mPADs) yielded comparable forces per micropost in the nN range across cell types. Quantitative 3D force measurements on humanized smooth muscle cell microtissues (SMTs) developed similar forces per cell. Larger forces were generated by MEKi-treated hPSC-vSMC and AoSMC versus controls.
    CONCLUSIONS: We have systematically studied the properties of hPSC-vSMC and performed comprehensive phenotypic and mechanical comparisons with AoSMC. These results demonstrate that synthetic hPSC-vSMC generated in vitro and cultured AoSMC derived from tissues are comparable and mechanically similar, but results with hPSC-vSMC are more reproducible.
    Keywords:  cell mechanics; human; induced pluripotent stem cells; phenotype switching; vascular smooth muscle cells
    DOI:  https://doi.org/10.1093/cvr/cvag242